The demise of the randomised controlled trial: Bibliometric study of the German-language health care literature, 1948 to 2004

被引:46
作者
Galandi D. [1 ]
Schwarzer G. [1 ]
Antes G. [1 ]
机构
[1] German Cochrane Center, Department of Medical Biometry and Statistics, University Hospital Freiburg, 79104 Freiburg
关键词
Journal Impact Factor; Publication Language; High Impact Journal; General Health Care; Language Bias;
D O I
10.1186/1471-2288-6-30
中图分类号
学科分类号
摘要
Background: In order to reduce systematic errors (such as language bias) and increase the precision of the summary treatment effect estimate, a comprehensive identification of randomised controlled trials (RCT), irrespective of publication language, is crucial in systematic reviews and meta-analyses. We identified trials in the German general health care literature. Methods: Eight German language general health care journals were searched for randomised controlled trials and analysed with respect to the number of published RCTs each year and the size of trials. Results: A total of 1618 trials were identified with a median total number of 43 patients per trial. Between 1970 and 2004 a small but constant rise in sample size from a median number of 30 to 60 patients per trial can be observed. The number of published trials was very low between 1948 and 1970, but increased between 1970 and 1986 to a maximum of 11.2 RCTs per journal and year. In the following time period a striking decline of the number of RCTs was observed. Between 1999 and 2001 only 0.8 RCTs per journal and year were published, in the next three years, the number of published trials increased to 1.7 RCTs per journal and year. Conclusion: German language general health care journals no longer have a role in the dissemination of trial results. The slight rise in the number of published RCTs in the last three years can be explained by a change of publication language from German to English of three of the analysed journals. © 2006 Galandi et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 10 条
  • [1] Egger M., Zellweger-Zahner T., Schneider M., Junker C., Lengeler C., Antes G., Language bias in randomised controlled trials published in English and German, Lancet, 350, pp. 326-329, (1997)
  • [2] Juni P., Holenstein F., Sterne J., Bartlett C., Egger M., Direction and impact of language bias in meta-analyses of controlled trials: Empirical study, Int J Epidemiol, 31, pp. 115-123, (2002)
  • [3] Pham B., Klassen T.P., Lawson M.L., Moher D., Language of publication restrictions in systematic reviews gave different results depending on wether the intervention was conventional or complementary, J Clin Epidemiol, 58, pp. 769-776, (2005)
  • [4] Moher D., Pham B., Klassen T.P., Schulz K.F., Berlin J.A., Jadad A.R., Liberati A., What contributions do languages other than English make on the results of meta-analyses?, J Clin Epidemiol, 53, pp. 964-972, (2000)
  • [5] McDonald S., Westby M., Clarke M., Lefebvre C., Number and size of randomized trials reported in general health care journals from 1948 to 1997, Int J Epidemiol, 31, pp. 125-127, (2002)
  • [6] McDonald S., Lefebvre C., Antes G., Galandi D., Gotzsche P., Hammarquist C., Haugh M., Jensen K.L., Kleijnen J., Loep M., Pistotti V., Ruther A., The Contribution of Handsearching European General Health Care Journals to the Cochrane Controlled Trials Register, Eval Health Prof, 25, pp. 65-75, (2002)
  • [7] Thornley B., Adams C., Content and quality of 2000 controlled trials in schizophrenia over 50 years, BMJ, 317, pp. 1181-1184, (1998)
  • [8] Dickersin K., Rennie D., Registering clinical trials, JAMA, 290, pp. 516-523, (2003)
  • [9] Evans T., Gulmezoglu M., Pan T., Registering clinical trials: An essential role for WHO, Lancet, 363, pp. 1413-1414, (2004)
  • [10] De Angelis C., Drazen J.M., Frizelle F.A., Haug C., Hoey J., Horton R., Kotzin S., Laine C., Marusic A., Overbeke A.J., Schroeder T.V., Sox H.C., Van Der Weyden M.B., Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors, N Engl J Med, 351, pp. 1250-1251, (2004)